Lesinurad/Allopurinol 200/300 FDC Tablets Bioavailability
Healthy
Recruiting
Phase Ⅰ
Bioavailability of Lesinurad and Intravenous [14C]Lesinurad
Healthy
Completed
Phase Ⅰ
Lesinurad Tablet Bioequivalence
Healthy
Completed
Phase Ⅰ
Lesinurad and Febuxostat Combination Extension Study in Gout
Gout
Active not recruiting
Phase Ⅲ
Lesinurad Interaction Study With Ranitidine
Healthy
Completed
Phase Ⅰ
Antacid Interaction Study
Healthy
Completed
Phase Ⅰ
Lesinurad Tablet Relative Bioavailability
Healthy
Completed
Phase Ⅰ
Lesinurad and Allopurinol Combination Extension Study in Gout
Gout
Active not recruiting
Phase Ⅲ
NSAID Drug Interaction Study
Gout
Completed
Phase Ⅰ
Metformin and Furosemide Drug-Drug Interaction Study
Healthy
Completed
Phase Ⅰ
Combination Treatment Study in Subjects With Tophaceous Gout With Lesinurad and Febuxostat
Tophaceous Gout
Completed
Phase Ⅲ
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
Gout
Completed
Phase Ⅲ
Single and Multiple Dose Study in Japanese
Gout
Completed
Phase Ⅰ
Open-Label Lesinurad Monotherapy Extension Study in Gout
Gout
Completed
Phase Ⅲ
Combining Lesinurad With Allopurinol in Inadequate Responders
Gout
Completed
Phase Ⅲ
Combining Lesinurad With Allopurinol in Inadequate Responders
Gout
Completed
Phase Ⅲ
Allopurinol Combination Study
Gout
Active not recruiting
Phase Ⅱ
Gout Dose Response Study
Hyperuricemia
Completed
Phase Ⅱ